Results 1 - 8 from 8 for "alvogen"
-
Antitrust Body Clears AI Sirona To Acquire Alvogen CEE
04.21.2020
-
Zentiva Group Buys Alvogen’s Operations In CEE, Including Labormed Plant In Romania
10.25.2019
-
Labormed Wants Drugs Cheaper Than RON10 Off Reimbursed List Over Clawback Tax
02.10.2015
Generics producer Labormed, part of Alvogen, is reassessing its medicines portfolio until March to remove products cheaper than RON10 from the reimbursed medicines list, as its sales rose 2% in value more
-
Advent Sold Labormed For $33M, 20% Of Acquisition Price
03.13.2014
Investment fund Advent sold Romanian generic drug producer Labormed last year to U.S. pharmaceutical company Alvogen for $33 million (EUR24 million), less than 20% of the acquisition price paid back more
-
Alvogen Aims For 15% Growth In 2014
10.02.2013
Alvogen and Labormed Pharma, which the former bought last December, will post 265 million lei (EUR60 million) revenue in 2013, says Laurentiu Scheusan, Alvogen’s executive vice-president in Central more
-
New Owner Of Labormed Wants Less Reliance On Romanian Market
04.09.2013
The priority of the new owner of pharmaceutical producer Labormed, Alvogen, is to make the company less reliant on the Romanian market, says Laurentiu Scheusan, Alvogen’s executive vice president of more
-
U.S. Alvogen Acquires Generic Drug Maker Labormed
01.31.2013
U.S. pharmaceutical company Alvogen on Thursday said it acquired Romanian generic drug producer Labormed in December 2012 from private equity firm Advent International. more
-
Negotiations On Labormed’s Takeover By U.S. Alvogen Almost Finished
01.14.2013
Negotiations on the takeover of Romanian drug producer Labormed by U.S. pharmaceutical company Alvogen from investment fund Advent are almost finished and a decision on the matter will be presented in more